Bintrafusp alfa enhances the antitumor efficacy of anti-VEGF and VEGF receptor kinase inhibitors in preclinical solid tumor models.

被引：0
|
作者：
Yeung, Tsz-Lun [1 ]
Lazorchak, Adam [1 ]
Yu, Huakui [1 ]
Qi, Jin [1 ]
Qin, Guozhong [1 ]
Marelli, Bo [1 ]
Fu, Kai [1 ]
Lan, Yan [1 ]
机构：
[1] Serono Res & Dev Inst Inc, Billerica, MA USA
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
443
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Expression of anti-VEGF antibody together with anti-EGFR or anti-FAP enhances tumor regression as a result of vaccinia virotherapy
    Huang, Ting
    Wang, Huiqiang
    Chen, Nanhai G.
    Frentzen, Alexa
    Minev, Boris
    Szalay, Aladar A.
    MOLECULAR THERAPY-ONCOLYTICS, 2015, 2 : 15003
  • [32] A Humanized Anti-VEGF Rabbit Monoclonal Antibody Inhibits Angiogenesis and Blocks Tumor Growth in Xenograft Models
    Yu, Yanlan
    Lee, Pierre
    Ke, Yaohuang
    Zhang, Yongke
    Yu, Qiu
    Lee, Jonathan
    Li, Mingzhen
    Song, Jialiang
    Chen, Jungang
    Dai, Jihong
    Do Couto, Fernando Jose Rebelo
    An, Zhiqiang
    Zhu, Weimin
    Yu, Guo-Liang
    PLOS ONE, 2010, 5 (02):
  • [33] Selenium enhances the anti-angiogenic effects of bevacuzimab (Anti-VEGF antibody) in human acute myeloid leukemia xenograft models
    Doro, Nathaniel C.
    Lal, Deepika
    Rustum, Youcef
    Wang, Eunice S.
    BLOOD, 2007, 110 (11) : 121B - 122B
  • [34] Cytokine levels correlate with immune cell infiltration after anti-VEGF therapy in preclinical mouse models of breast cancer
    Roland, C. L.
    Lynn, K. D.
    Toombs, J. E.
    Dineen, S. P.
    Schwarz, R. E.
    Udugamasooriya, D. G.
    Brekken, R. A.
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 : S43 - S43
  • [35] Cytokine Levels Correlate with Immune Cell Infiltration after Anti-VEGF Therapy in Preclinical Mouse Models of Breast Cancer
    Roland, Christina L.
    Lynn, Kristi D.
    Toombs, Jason E.
    Dineen, Sean P.
    Udugamasooriya, D. Gomika
    Brekken, Rolf A.
    PLOS ONE, 2009, 4 (11):
  • [36] Synergistic antitumor effects of cMet inhibitor in combination with anti-VEGF in colorectal cancer patient-derived xenograft models
    Chen, Xiangheng
    Guan, Zhonghai
    Lu, Jun
    Wang, Haohao
    Zuo, Zhongkun
    Ye, Fei
    Huang, Jiangsheng
    Teng, Lisong
    JOURNAL OF CANCER, 2018, 9 (07): : 1207 - 1217
  • [37] Selective ITK blockade induces antitumor responses and enhances efficacy to immune checkpoint inhibitors in preclinical models
    Hsu, Lih-Yun
    Pawar, Rahul D.
    Li, Dan
    Ghosh, Poorva
    Nguyen, Kevin
    Williams, Carlene
    Song, Yuqin
    Ding, Ning
    Verner, Erik
    Miller, Richard A.
    CANCER RESEARCH, 2023, 83 (07)
  • [38] Oncolytic Vaccinia Virus Encoding an Anti-VEGF Antibody Improves the Efficacy of Fractionated Radiation in Lung Tumor Xenografts
    Advani, S. J.
    Buckel, L.
    Frentzen, A.
    Scanderbeg, D.
    Chen, N.
    Zhang, Q.
    Yu, Y.
    Mundt, A. J.
    Szalay, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S737 - S737
  • [39] Combination of fractionated irradiation with anti-VEGF expressing vaccinia virus therapy enhances tumor control by simultaneous radiosensitization of tumor associated endothelium
    Buckel, Lisa
    Advani, Sunil J.
    Frentzen, Alexa
    Zhang, Qian
    Yu, Yong A.
    Chen, Nanhai G.
    Ehrig, Klaas
    Stritzker, Jochen
    Mundt, Arno J.
    Szalay, Aladar A.
    INTERNATIONAL JOURNAL OF CANCER, 2013, 133 (12) : 2989 - 2999
  • [40] Efficacy of VEGFR2 Targeted mAb Therapy in Preclinical Colorectal Cancer Model Resistant to Anti-VEGF mAb Therapy
    Surguladze, D.
    Malaby, J.
    Prewett, M.
    Duignan, I.
    Rutstein, M.
    Yao, Y. M.
    Schwartz, J. D.
    Pytowski, B.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 13 - 13
12345